Pharmaxis sells Australian distribution rights for Bronchitol and Aridol for A$2 million

Retrieved on: 2021-07-01 03:00:00

Tags for this article:

Click the tags to see associated articles and topics

Pharmaxis sells Australian distribution rights for Bronchitol and Aridol for A$2 million. View article details on hiswai:

Excerpt

Marketing authorisations acquired. Australian listed entity BTC Health is a high-growth company, focused on making world-class innovative medical ...

Article found on: www.proactiveinvestors.com